Study of Methylnaltrexone in Opioid-Induced Constipation Patients
Status:
Unknown status
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind , placebo-controlled trail to investigate the
safety and efficacy of subcutaneous methylnaltrexone for treating opioid-induced constipation
in patients with advanced illness.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd